instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | De novo lupus nephritis during treatment with belimumab.
In light of reports of de novo LN during belimumab (BLM) treatment, we sought to determine its frequency and contributing or protective factors in a real-life setting.
Patients with SLE who received BLM between 2011 and 2017 at five European academic practices... | BELIMUMAB, HYDROXYCHLOROQUINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33341888 | 18,694,286 | 2021-09-01 |
What was the administration route of drug 'BELIMUMAB'? | De novo lupus nephritis during treatment with belimumab.
In light of reports of de novo LN during belimumab (BLM) treatment, we sought to determine its frequency and contributing or protective factors in a real-life setting.
Patients with SLE who received BLM between 2011 and 2017 at five European academic practices... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33341888 | 18,692,184 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cellulitis'. | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | HYALURONIC ACID, LIDOCAINE | DrugsGivenReaction | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site inflammation'. | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | HYALURONIC ACID, LIDOCAINE | DrugsGivenReaction | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
What was the dosage of drug 'HYALURONIC ACID'? | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | VYC?20L (HYALURONIC ACID SOFT TISSUE FILLER WITH LIDOCAINE) | DrugDosageText | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
What was the dosage of drug 'LIDOCAINE'? | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | VYC?20L (HYALURONIC ACID SOFT TISSUE FILLER WITH LIDOCAINE) | DrugDosageText | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
What was the outcome of reaction 'Cellulitis'? | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | Recovered | ReactionOutcome | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
What was the outcome of reaction 'Injection site inflammation'? | Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.
VYC-20L is a hyaluronic acid soft tissue filler with lidocaine designed to restore facial volume.
Evaluate the safety and effectiveness of VYC-20L in patients with chin retrusion.
Adults with chin retrusion were randomized (... | Recovered | ReactionOutcome | CC BY-NC-ND | 33347003 | 18,840,355 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacteraemia'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peritonitis'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia klebsiella'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomembranous colitis'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | CEFAZOLIN, METRONIDAZOLE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the administration route of drug 'METRONIDAZOLE'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the administration route of drug 'NOREPINEPHRINE'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33352444 | 18,700,665 | 2021-01 |
What was the administration route of drug 'VANCOMYCIN'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Bacteraemia'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Klebsiella infection'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,700,665 | 2021-01 |
What was the outcome of reaction 'Peritonitis'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Pneumonia klebsiella'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Pseudomembranous colitis'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Sepsis'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
What was the outcome of reaction 'Septic shock'? | Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneumoniae after osteomyelitis surgery: A case report.
BACKGROUND
Clostridium difficile is one of the most common healthcare-associated infections. Pseudomembranous colitis is ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33352444 | 18,764,487 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
Approximately 20% of antibody-mediated rejection (ABMR) episodes in the absence of donor-specific antibodies against human leucocyte antigens (HLA-DSA) in pediatric and adult kidney transplant recipients are... | CANDESARTAN, CYCLOSPORINE, ILOPROST, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 33355703 | 19,773,230 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
Approximately 20% of antibody-mediated rejection (ABMR) episodes in the absence of donor-specific antibodies against human leucocyte antigens (HLA-DSA) in pediatric and adult kidney transplant recipients are... | CANDESARTAN, CYCLOSPORINE, ILOPROST, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 33355703 | 19,773,230 | 2021-03 |
What was the dosage of drug 'ILOPROST TROMETHAMINE'? | Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
Approximately 20% of antibody-mediated rejection (ABMR) episodes in the absence of donor-specific antibodies against human leucocyte antigens (HLA-DSA) in pediatric and adult kidney transplant recipients are... | 0.5 NG/KG/MIN INFUSED OVER 6 HOURS | DrugDosageText | CC BY | 33355703 | 18,692,004 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A case report of Vagus nerve stimulation for intractable hiccups.
BACKGROUND
Intractable hiccups frequently result from an underlying pathology and can cause considerable illness in the patients. Initial remedies such as drinking cold water, induction of emesis, carotid sinus massage or Valsalva manoeuvre all seem to w... | BACLOFEN, CARBAMAZEPINE, CHLORPROMAZINE, DOMPERIDONE, GABAPENTIN, LANSOPRAZOLE, LEVETIRACETAM, METOCLOPRAMIDE, OMEPRAZOLE, PROCHLORPERAZINE | DrugsGivenReaction | CC BY-NC-ND | 33360634 | 18,817,592 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | A case report of Vagus nerve stimulation for intractable hiccups.
BACKGROUND
Intractable hiccups frequently result from an underlying pathology and can cause considerable illness in the patients. Initial remedies such as drinking cold water, induction of emesis, carotid sinus massage or Valsalva manoeuvre all seem to w... | BACLOFEN, CARBAMAZEPINE, CHLORPROMAZINE, DOMPERIDONE, GABAPENTIN, LANSOPRAZOLE, LEVETIRACETAM, METOCLOPRAMIDE, OMEPRAZOLE, PROCHLORPERAZINE | DrugsGivenReaction | CC BY-NC-ND | 33360634 | 18,817,592 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | A case report of Vagus nerve stimulation for intractable hiccups.
BACKGROUND
Intractable hiccups frequently result from an underlying pathology and can cause considerable illness in the patients. Initial remedies such as drinking cold water, induction of emesis, carotid sinus massage or Valsalva manoeuvre all seem to w... | BACLOFEN, CARBAMAZEPINE, CHLORPROMAZINE, DOMPERIDONE, GABAPENTIN, LANSOPRAZOLE, LEVETIRACETAM, METOCLOPRAMIDE, OMEPRAZOLE, PROCHLORPERAZINE | DrugsGivenReaction | CC BY-NC-ND | 33360634 | 18,817,592 | 2021-01 |
What was the dosage of drug 'LEVETIRACETAM'? | A case report of Vagus nerve stimulation for intractable hiccups.
BACKGROUND
Intractable hiccups frequently result from an underlying pathology and can cause considerable illness in the patients. Initial remedies such as drinking cold water, induction of emesis, carotid sinus massage or Valsalva manoeuvre all seem to w... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33360634 | 18,817,592 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with C... | METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33361678 | 19,517,386 | 2021-05-15 |
What was the administration route of drug 'PREDNISOLONE'? | Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with C... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33361678 | 19,517,386 | 2021-05-15 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with C... | 3 COURSES OF PULSE THERAPY | DrugDosageText | CC BY-NC-ND | 33361678 | 19,517,386 | 2021-05-15 |
What was the dosage of drug 'PREDNISOLONE'? | Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with C... | 30 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33361678 | 19,517,386 | 2021-05-15 |
What was the outcome of reaction 'Paraesthesia'? | Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with C... | Recovered | ReactionOutcome | CC BY-NC-ND | 33361678 | 19,517,386 | 2021-05-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Calciphylaxis: The potential diagnostic role of radiologists.
Calciphylaxis is a deadly disease that is currently diagnosed through a skin biopsy of resultant necrotic lesions despite many cases lacking this characteristic finding. Recently, research has demonstrated the ability of various radiologic techniques to dete... | CALCIUM ACETATE, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 33363673 | 18,705,870 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Splenic infarction'. | Calciphylaxis: The potential diagnostic role of radiologists.
Calciphylaxis is a deadly disease that is currently diagnosed through a skin biopsy of resultant necrotic lesions despite many cases lacking this characteristic finding. Recently, research has demonstrated the ability of various radiologic techniques to dete... | CALCIUM ACETATE | DrugsGivenReaction | CC BY-NC-ND | 33363673 | 18,722,566 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma muscle'. | Psoas muscle hematoma presenting as painful monoplegia.
I present here a case of psoas (retroperitoneal) hematoma; which is a rare, but potentially life-threatening acute condition, with a 30-day mortality of 10% from bleeding in the retroperitoneal space without associated trauma or iatrogenic intervention. A 59-year-... | WARFARIN SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33363683 | 18,813,994 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'International normalised ratio increased'. | Psoas muscle hematoma presenting as painful monoplegia.
I present here a case of psoas (retroperitoneal) hematoma; which is a rare, but potentially life-threatening acute condition, with a 30-day mortality of 10% from bleeding in the retroperitoneal space without associated trauma or iatrogenic intervention. A 59-year-... | WARFARIN SODIUM | DrugsGivenReaction | CC BY-NC-ND | 33363683 | 18,813,994 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast necrosis'. | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | CAPECITABINE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematotoxicity'. | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | CAPECITABINE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mastitis'. | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | CAPECITABINE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | CAPECITABINE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | CAPECITABINE, TEMOZOLOMIDE | DrugsGivenReaction | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the administration route of drug 'CAPECITABINE'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the administration route of drug 'EDOTREOTIDE LUTETIUM LU-177'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33363730 | 18,826,407 | 2021-01 |
What was the administration route of drug 'TEMOZOLOMIDE'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the dosage of drug 'EDOTREOTIDE LUTETIUM LU-177'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | FOR 4 CYCLES | DrugDosageText | CC BY-NC-ND | 33363730 | 18,826,407 | 2021-01 |
What was the dosage of drug 'TEMOZOLOMIDE'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | 150 MILLIGRAM/SQ. METER | DrugDosageText | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the outcome of reaction 'Breast necrosis'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Recovered | ReactionOutcome | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the outcome of reaction 'Haematotoxicity'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Recovered | ReactionOutcome | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the outcome of reaction 'Mastitis'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Recovered | ReactionOutcome | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the outcome of reaction 'Myelosuppression'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Recovered | ReactionOutcome | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
What was the outcome of reaction 'Pancytopenia'? | A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report.
Neuroendocrine tumors (NET) are rare and demonstrate variable clinical behavior depending on the degree of tumor differentiation. Patients with po... | Recovered | ReactionOutcome | CC BY-NC-ND | 33363730 | 18,672,294 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | A rare case of extensive Staphylococcus aureus sternoclavicular septic arthritis treated without surgical intervention.
This is a rare case of a 55 year-old immunocompetent female who developed Methicillin sensitive Staphylococcus aureus sternoclavicular septic arthritis. The infection was not limited to the joint spac... | CEFAZOLIN | DrugsGivenReaction | CC BY-NC-ND | 33364169 | 19,703,399 | 2021 |
What was the administration route of drug 'CEFAZOLIN'? | A rare case of extensive Staphylococcus aureus sternoclavicular septic arthritis treated without surgical intervention.
This is a rare case of a 55 year-old immunocompetent female who developed Methicillin sensitive Staphylococcus aureus sternoclavicular septic arthritis. The infection was not limited to the joint spac... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33364169 | 19,703,399 | 2021 |
What was the dosage of drug 'CEFAZOLIN'? | A rare case of extensive Staphylococcus aureus sternoclavicular septic arthritis treated without surgical intervention.
This is a rare case of a 55 year-old immunocompetent female who developed Methicillin sensitive Staphylococcus aureus sternoclavicular septic arthritis. The infection was not limited to the joint spac... | 2 g (grams). | DrugDosage | CC BY-NC-ND | 33364169 | 19,703,399 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse drug reaction'. | Ovarian teratoma with pituitary tissue: A case report.
Ovarian cysts and specifically ovarian teratomas are a common finding in young patients. These cysts display histological cell types from all three cells lines: endodermal, ectodermal and mesodermal origins. A 22-year-old woman who displayed classic signs of cortis... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33364180 | 20,870,128 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Ovarian teratoma with pituitary tissue: A case report.
Ovarian cysts and specifically ovarian teratomas are a common finding in young patients. These cysts display histological cell types from all three cells lines: endodermal, ectodermal and mesodermal origins. A 22-year-old woman who displayed classic signs of cortis... | METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33364180 | 20,870,128 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood parathyroid hormone decreased'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Clavicle fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Femur fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fibula fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foot fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Humerus fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalciuria'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrocalcinosis'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tibia fracture'. | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the administration route of drug 'DENOSUMAB'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Clavicle fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Femur fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Fibula fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Foot fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Humerus fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Hypercalcaemia'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
What was the outcome of reaction 'Tibia fracture'? | Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis.
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with... | Recovered | ReactionOutcome | CC BY-NC-ND | 33364264 | 18,706,353 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Insomnia'. | Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literature.
This is a case of recurrent intravascular leiomyomatosis in a pre-menopausal woman of African-Caribbean heritage. She presented in 2006 with multiple uterine leiomyomata, tumour invading t... | GOSERELIN, LETROZOLE | DrugsGivenReaction | CC BY-NC-ND | 33364287 | 18,880,673 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Libido decreased'. | Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literature.
This is a case of recurrent intravascular leiomyomatosis in a pre-menopausal woman of African-Caribbean heritage. She presented in 2006 with multiple uterine leiomyomata, tumour invading t... | GOSERELIN, LETROZOLE | DrugsGivenReaction | CC BY-NC-ND | 33364287 | 18,880,673 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Vitamin D deficiency in the pathogenesis of leiomyoma and intravascular leiomyomatosis: A case report and review of the literature.
This is a case of recurrent intravascular leiomyomatosis in a pre-menopausal woman of African-Caribbean heritage. She presented in 2006 with multiple uterine leiomyomata, tumour invading t... | GOSERELIN, LETROZOLE | DrugsGivenReaction | CC BY-NC-ND | 33364287 | 18,880,673 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coma'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cranial nerve disorder'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalomyelitis'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect route of product administration'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental impairment'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelopathy'. | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | CYTARABINE, DAUNORUBICIN, HYDROCORTISONE, IDARUBICIN, METHOTREXATE, TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the administration route of drug 'HYDROCORTISONE'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the administration route of drug 'METHOTREXATE'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the dosage of drug 'HYDROCORTISONE'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | RECEIVED HIS FIRST DOSE OF PROPHYLACTIC INTRATHECAL CHEMOTHERAPY WITH METHOTREXATE, CYTARABINE, A... | DrugDosageText | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the dosage of drug 'IDARUBICIN'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | THE PATIENT WAS SUBSEQUENTLY ADMITTED IN AUGUST 2010 FOR THE FIRST CYCLE OF CONSOLIDATION THERAPY... | DrugDosageText | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the dosage of drug 'METHOTREXATE'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | RECEIVED HIS FIRST DOSE OF PROPHYLACTIC INTRATHECAL CHEMOTHERAPY WITH METHOTREXATE, CYTARABINE, A... | DrugDosageText | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the outcome of reaction 'Coma'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the outcome of reaction 'Cranial nerve disorder'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Fatal | ReactionOutcome | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the outcome of reaction 'Encephalomyelitis'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Fatal | ReactionOutcome | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the outcome of reaction 'Mental impairment'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Fatal | ReactionOutcome | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
What was the outcome of reaction 'Myelopathy'? | Inadvertent intrathecal administration of daunomycin resulting in fatality: Case report and therapeutic considerations.
Daunomycin is a chemotherapeutic agent of the anthracycline family that is administered intravenously, most commonly in combination therapy. The authors report the first known adult case of inadverten... | Fatal | ReactionOutcome | CC BY-NC-ND | 33364452 | 18,941,912 | 2021-03 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.